IGC — Topline data
Q4 2026
IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026Source filing
catalyst calendar
IGC PHARMA INC · Data as of 2026-10-25
Q4 2026
IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026Source filing